You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 19, 2024

METHADOSE Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Methadose, and what generic alternatives are available?

Methadose is a drug marketed by Specgx Llc and is included in three NDAs.

The generic ingredient in METHADOSE is methadone hydrochloride. There are thirteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the methadone hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Methadose

A generic version of METHADOSE was approved as methadone hydrochloride by ROXANE on March 8th, 1983.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for METHADOSE?
  • What are the global sales for METHADOSE?
  • What is Average Wholesale Price for METHADOSE?
Drug patent expirations by year for METHADOSE
Drug Prices for METHADOSE

See drug prices for METHADOSE

Recent Clinical Trials for METHADOSE

Identify potential brand extensions & 505(b)(2) entrants

The Ottawa HospitalPhase 3
Bruyere Research InstitutePhase 3
Ottawa Hospital Research InstitutePhase 3

See all METHADOSE clinical trials

Pharmacology for METHADOSE
Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists

US Patents and Regulatory Information for METHADOSE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Specgx Llc METHADOSE methadone hydrochloride CONCENTRATE;ORAL 017116-002 Approved Prior to Jan 1, 1982 AA RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Specgx Llc METHADOSE methadone hydrochloride TABLET;ORAL 040050-002 Apr 15, 1993 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Specgx Llc METHADOSE methadone hydrochloride TABLET, FOR SUSPENSION;ORAL 074184-001 Apr 29, 1993 AA RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Specgx Llc METHADOSE methadone hydrochloride TABLET;ORAL 040050-001 Apr 15, 1993 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.